IGF2BP2 and nasopharyngeal carcinoma: Several of these epigenetic regulators, such as METTL3, IGF2BP2, and HOXA9, exhibit strong associations with recurrence risk and radioresistance in NPC, supporting their potential as prognostic biomarkers and therapeutic targets.